Biotech/Pharma

KGK Science Inc.

WDC advised on approximately $6M of debt and equity financing for KGK Science Limited, a leading health and wellness focused private contract research organization based in London, Ontario. KGK was subsequently acquired by Auxly Cannabis Group Inc. (TSX.V: XLY)

Bradmer Pharmaceuticals Inc.

Two brokered private placement offerings of shares for aggregate gross proceeds of approximately $1.3 million.